T44.2X4

Clinical Causes: Accidental ingestion of ganglionic blocking drugs Overdose due to medication mismanagement Misuse of prescribed medications Exposure to counterfeit or contaminated drugs containing ganglionic blockers Inadvertent administration during medical procedures Intentional poisoning or overdose

Key Symptoms: Severe hypotension (low blood pressure) Bradycardia (slow heart rate) Difficulty breathing or respiratory distress Loss of consciousness or dizziness Blurred vision Dry mouth and dry skin Urinary retention Gastrointestinal disturbances such as nausea or vomiting Muscle weakness or fatigue Altered mental state or confusion

Diagnosis Path: The diagnosis of poisoning by ganglionic blocking drugs involves a combination of clinical evaluation and laboratory tests. Healthcare providers may perform blood tests to detect the presence of the drug or its metabolites in the bloodstream. Vital signs are closely monitored to assess blood pressure, heart rate, and respiratory status. Medical history, including recent medication exposure or possible ingestion, also plays a crucial role. In some cases, additional tests such as electrocardiograms (ECGs) might be used to evaluate cardiac effects, and imaging studies could be employed to rule out other causes of symptoms.

Treatment Protocols: Ensuring airway patency and providing supplemental oxygen if needed Monitoring and managing blood pressure, potentially with intravenous fluids or vasopressors Treating bradycardia with medications such as atropine Using activated charcoal if ingestion was recent to limit absorption Preparation for possible administration of specific antidotes if available Continuous cardiac and vital sign monitoring Addressing symptoms like dry mouth, urinary retention, or gastrointestinal issues Providing psychiatric or psychological support if poisoning was intentional Arranging for hospitalization in severe cases for close observation and advanced interventions